UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021819
Receipt number R000025151
Scientific Title [18F]THK-5351 PET imaging of tau deposits in neurological disorders
Date of disclosure of the study information 2016/05/01
Last modified on 2018/07/14 16:42:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

[18F]THK-5351 PET imaging of tau deposits in neurological disorders

Acronym

[18F]THK-5351 PET imaging in neurological disorders

Scientific Title

[18F]THK-5351 PET imaging of tau deposits in neurological disorders

Scientific Title:Acronym

[18F]THK-5351 PET imaging in neurological disorders

Region

Japan


Condition

Condition

corticobasal syndrome, other neurodegenerative disorders, and normal volunteers

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Utility evaluation of in vivo visualization of tau deposition by [18F]THK-5351 PET in corticobasal syndrome and other neurodegenerative disorders

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

[18F]THK-5351 uptake in frontal and parietal cortexes of corticobasal syndrome

Key secondary outcomes

[18F]THK-5351 uptake in subcortical white matter or brainstem of corticobasal syndrome


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

After injecting 185 MBq of 18F-THK5351, PET images were obtained and were used for the evaluation of group differences.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Probable CBS are diagnosed based on the modified Cambridge criteria.
2) Written informed consent are obtained from each patient or their guardians after being given a complete description of the study.

Key exclusion criteria

1) neuropsychiatric disorder except for corticobasal syndrome
2) severe cardiovascular disease or liver dysfunction

Target sample size

160


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akio Kikuchi

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Neurology

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan

TEL

022-717-7189

Email

akikuchi@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akio Kikuchi

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Neurology

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan

TEL

022-717-7189

Homepage URL


Email

akikuchi@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 01 Month 27 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 07 Day

Last modified on

2018 Year 07 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025151


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name